MONDAY, Feb. 10, 2020 — Two experimental drugs do not appear to slow memory loss or mental decline in patients in the early stages of a rare, inherited form of Alzheimer’s disease, according to initial results from a clinical trial. The international phase 2 and 3 clinical trial separately evaluated the two drugs — solanezumab […]
Scientists in San Diego are preparing to screen thousands of people globally to find candidates who are well-suited to take an experimental drug that is designed to slow, and possibly stop, the progression of Alzheimer’s disease. The study will be led by the University of Southern California’s Alzheimer’s Therapeutic Research Institute—or ATRI—in Sorrento Mesa. Researchers […]
